Discovery May Overcome Key Hurdle in Cancer Immunotherapy
Scientists at Ohio State have uncovered why cancer immunotherapy often fails, tracing it to the malfunction of T cells burdened by misfolded proteins. Addressing this malfunction could enhance the effectiveness of immunotherapy treatments.